Antimicrobial Susceptibility Testing Market Report
RA01343
Antimicrobial Susceptibility Testing Market by Product (Manual Tests, Automated Instruments, and Consumables & Media) Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, and Others) Application (Drug Development, Susceptibility Testing, and Others) End-use (Hospitals, Diagnostic Laboratories, Biotechnology & Pharmaceutical Companies, and Others) and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Antimicrobial Susceptibility Testing Overview
A laboratory procedure called antimicrobial susceptibility testing is used to assess how well different antimicrobial medications work against certain pathogens, such as bacteria or fungi, it helps in the selection of the most effective therapy for infections and directs the creation of programs for the responsible use of antibiotics.
Antimicrobial susceptibility testing determines how efficiently certain drugs kill or prevent the development of bacteria, it is critical because certain germs can develop immunity to antibiotics and making them less effective in treating illnesses. Healthcare practitioners can find the best treatment choices by assessing the susceptibility of bacteria to various medications.
During the testing process, a sample of the microorganism is obtained, usually from a patient's blood, urine, or other body fluids. The sample is then grown in a laboratory to obtain a pure culture. Once the culture is established, it is exposed to different antimicrobial drugs to observe how the microorganism responds. There are different methods used for antimicrobial susceptibility testing, including the disk diffusion method and the broth microdilution method. Overall, antimicrobial susceptibility testing plays a vital role in guiding appropriate antibiotic therapy. It helps healthcare providers choose effective drugs and prevent the spread of antimicrobial resistance, ultimately improving patient outcomes and public health.
Global Antimicrobial Susceptibility Testing Market Analysis
The global antimicrobial susceptibility testing market size was $3.7 billion in 2022 and is predicted to grow with a CAGR of 5.7%, by generating a revenue of $6.3 billion by 2032.
COVID-19 Impact on Global Antimicrobial Susceptibility Testing Market
The COVID-19 pandemic has had a significant impact on the antimicrobial susceptibility testing market. Throughout the pandemic there has been an increased focus on infectious illnesses and the significance of efficient antibiotic therapies, this has raised the demand for antimicrobial susceptibility testing, as healthcare providers must decide the best medications to treat patients with bacterial infections, particularly COVID-19 infections. The pandemic has also drawn attention to the issue of antimicrobial resistance (AMR), which occurs when germs become immune to the medications used to treat them. As a result, to avoid the overuse or abuse of antibiotics, antimicrobial susceptibility testing is much more important in assisting in the selection of the most appropriate treatments. However, the COVID-19 pandemic has also presented challenges to the antimicrobial susceptibility testing market. The healthcare system's focus and resources have been primarily directed toward managing the pandemic, leading to a decrease in routine diagnostic testing for other infections. This reduction in non-COVID-19 testing has impacted the demand for antimicrobial susceptibility testing, as fewer tests are being conducted overall.
In summary, the COVID-19 pandemic has both positively and negatively influenced the antimicrobial susceptibility testing market. The increased awareness of infectious diseases and antimicrobial resistance has driven up the demand for these tests. However, the diversion of resources and reduced testing for non-COVID-19 infections, along with supply chain disruptions, have posed challenges to the market.
Unique Advantages of Antimicrobial Susceptibility Testing in Medical
Field to Drive the Market Growth
Antimicrobial susceptibility testing has several positive points that contribute to its importance in healthcare. Accurate treatment selection and antimicrobial susceptibility testing help healthcare professionals determine which antibiotics are effective against specific bacteria. By identifying the most suitable antibiotic, doctors can prescribe targeted treatments that are more likely to eliminate the infection. In precision medicine, every individual and infection are unique. Antimicrobial susceptibility testing allows healthcare providers to offer personalized treatment based on the specific susceptibility patterns of the pathogen causing the infection. This approach enhances the effectiveness of treatment while minimizing unnecessary antibiotic use. Antimicrobial susceptibility testing gives critical information for making educated decisions about patient care, the results of the tests assist doctors in determining the most optimal treatment choices, such as antibiotic choice and dosage and length of medication. Antimicrobial susceptibility testing also enhances patient safety by identifying the susceptibility patterns of bacterial infections. It aids in the prevention of treatment failures, relapses, and problems caused by poor antibiotic therapy. Moreover, antimicrobial susceptibility testing in public health plays an important role in monitoring and tracking of antibiotic resistance at both the local and global levels. Testing data assists public health officials in tracking trends, detecting new resistance patterns, and implementing necessary actions to restrict the spread of resistant microorganisms.
Overall, antimicrobial susceptibility testing is a useful tool for directing proper antibiotic usage, enhancing patient care, reducing antibiotic resistance, and supporting public health efforts to battle infectious illnesses
Limitation of Antimicrobial Susceptibility Testing to Restrain the Market Growth
Antimicrobial susceptibility testing is a time-consuming technique that might take many hours or even days to complete, this delay in proper treatment might have a negative effect on the treatment results. Antibiotic susceptibility testing with a narrow spectrum frequently focuses on a small number of drugs and may not cover the entire spectrum of available medicines; if the tested antibiotics do not specifically target the bacteria causing the infection, an ineffective antibiotic may be chosen. Moreover, conducting antimicrobial susceptibility testing requires specialized equipment and materials, which can be expensive. This cost can be a burden for healthcare facilities, particularly in resource-limited settings. In addition, interpreting antimicrobial susceptibility test results requires expertise and knowledge of the specific bacteria being tested. The results can be difficult to interpret accurately, leading to potential errors in treatment decisions.
Antimicrobial susceptibility testing methods may also have limitations in accurately predicting the effectiveness of antibiotics in a clinical setting. Factors such as the test methodology, bacterial growth conditions, and genetic variability of the bacteria can influence the accuracy of the results. Also, there may be variations in antimicrobial susceptibility testing methods and interpretation criteria among different laboratories. This lack of standardization can result in inconsistent and unreliable results, making it challenging to compare data across different settings. Antimicrobial susceptibility testing, despite these drawbacks, is still a useful technique for assisting antibiotic treatment selection and controlling antimicrobial resistance.
Advancements in Antimicrobial Susceptibility Testing to Drive Excellent Opportunities for Future
Antimicrobial susceptibility testing is likely to advance and improve in the future. These improvements will aim to provide more accurate and efficient results, helping healthcare professionals select the most effective antibiotics for treating infections. One potential upgrade could involve the development of faster testing methods. Antimicrobial susceptibility testing results might now take many hours or even days to come in, however, future developments could make it possible to identify bacterial strains and their susceptibilities to various antibiotics more quickly. This would enable healthcare providers to start appropriate treatment sooner, improving patient outcomes. Another area of improvement could be the utilization of more advanced technology in testing procedures. For example, the integration of automated systems or robotics may streamline the testing process and reduce the potential for human error. These technological enhancements could increase the efficiency and reliability of antimicrobial susceptibility testing. Additionally, researchers may continue to discover new markers or biomarkers that can provide valuable information about bacterial resistance. By identifying specific genetic or molecular characteristics, scientists can develop tests that rapidly detect antibiotic resistance mechanisms. Furthermore, future antibiotic susceptibility testing may benefit considerably from the use of artificial intelligence (AI) and machine learning algorithms, which means that vast data sets can be analyzed by these technologies to identify patterns that humans would find difficult to notice. Overall, future advancements in antimicrobial susceptibility testing are likely to focus on speed, accuracy, automation, and the integration of advanced technologies. These upgrades will improve the efficiency of testing, aid in the selection of optimal antibiotics, and ultimately contribute to more effective and personalized treatment strategies for infectious diseases.
Global Antimicrobial Susceptibility Testing Market, by Product, 2022
The manual tests sub-segment accounted for the highest market share in 2022. Manual tests in antimicrobial susceptibility testing services have several positive points. For instance, manual tests allow for flexibility in adjusting testing protocols and conditions according to specific needs. This enables researchers and technicians to customize the testing process to different antimicrobial agents or pathogens. Compared to automated testing methods, manual tests are generally more affordable and require less sophisticated equipment. This makes them a cost-effective option, particularly for laboratories with limited resources or budgets. Moreover, manual tests can be performed on a wide range of microorganisms, including bacteria and fungi. They are not restricted to specific types or strains, allowing for comprehensive testing across various pathogens. Customization and manual testing allow for customization in terms of selecting the appropriate culture media, the concentration of antimicrobial agents, and other test parameters. This customization ensures the accuracy and relevance of the results for specific research or diagnostic purposes. Furthermore, manual testing provides greater control over the testing process, allowing technicians to closely monitor and adjust parameters such as incubation time and temperature. This control enhances the precision and reliability of the test results.
Global Antimicrobial Susceptibility Testing Market, by Technique, 2022
The disk diffusion sub-segment accounted for the highest market share in 2022. The disk diffusion technique in antimicrobial susceptibility testing has several positive points. The disk diffusion technique is relatively simple to perform and does not require expensive equipment or specialized training. It can be conducted in most laboratories with basic resources. This technique also provides relatively fast results compared to other methods, such as broth microdilution. The visible zones of inhibition around the antibiotic disks allow for a quick assessment of the susceptibility or resistance of the bacteria being tested. Moreover, this technique can be used to test the susceptibility of a wide range of bacteria to various antibiotics. It is effective for both aerobic and facultative anaerobic bacteria. Moreover, the disk diffusion technique allows for testing multiple antibiotics simultaneously on a single agar plate, which saves time and resources. This helps in determining the most appropriate antibiotic treatment for a particular infection. This technique also provides both qualitative information (susceptible, intermediate, or resistant) and quantitative data (zone diameter measurements). This allows for a more comprehensive understanding of the bacteria's response to different antibiotics.
Global Antimicrobial Susceptibility Testing Market, by Application, 2022
The susceptibility testing sub-segment accounted for the highest market share in 2022. The dominance of susceptibility testing application in antimicrobial susceptibility testing services can be attributed to its crucial role in determining the most effective antibiotics to combat bacterial infections. By testing the susceptibility of bacteria to different antibiotics, healthcare professionals can identify the most appropriate treatment options for patients. This application allows them to understand which antibiotics will effectively inhibit the growth of specific bacteria and which ones may be less effective or ineffective altogether. Such information helps healthcare providers make informed decisions about antibiotic therapy, ensuring that patients receive the most suitable and targeted treatment for their infections. Therefore, susceptibility testing application has become dominant in antimicrobial susceptibility testing services due to its vital contribution in guiding effective antibiotic treatment.
Global Antimicrobial Susceptibility Testing Market, by End-Use, 2022
The hospitals sub-segment accounted for the highest market share in 2022. Hospitals use antimicrobial susceptibility testing to discover whether drugs are effective against certain microorganisms, this testing entails culturing bacteria from a patient's sample in the laboratory and exposing them to several antibiotics to see which ones can kill or restrict their development. By doing these tests, hospitals can determine which medications are most suited for a patient's infection. Hospitals rely on antimicrobial susceptibility testing to make educated judgments regarding antibiotic therapy because of their crucial role in patient care, this is crucial because improper or excessive use of antibiotics can result in the growth of germs that are resistant to drugs and make illnesses more challenging to cure. Therefore, to guarantee that their patients receive effective and personalized care, hospitals require accurate and timely information concerning antibiotic susceptibility. In summary, hospitals are the primary users of antimicrobial susceptibility testing services because they need this information to guide their antibiotic prescribing decisions and provide optimal care to patients.
Global Antimicrobial Susceptibility Testing Market Share, by Region, 2022
The North America antimicrobial susceptibility testing market generated the highest revenue in 2022. North America is considered the dominant region for the use of antimicrobial susceptibility testing due to several key factors. First and foremost, the region has well-established healthcare systems and advanced laboratory infrastructure, which allows for widespread access to and implementation of such testing. Furthermore, there is a high degree of awareness and emphasis on patient safety and infection control procedures in North America, and antimicrobial resistance is being closely monitored and combated, necessitating the use of antimicrobial susceptibility testing to guide proper treatment decisions. North American institutions and organizations play an important role in conducting studies, formulating recommendations, and encouraging the use of standardized testing procedures, all of which contribute to the broad use of antimicrobial susceptibility testing.
Competitive Scenario in the Global Antimicrobial Susceptibility Testing Market
Investment and new product launch are common strategies followed by major market players. Some of the leading players in the antimicrobial susceptibility testing market are Bio-Rad Laboratories Inc., Merck & Co., Inc., Thermo Fisher Scientific Inc, Danaher Corporation, BD, bioMérieux SA, Creative Diagnostics, Hi-Media Laboratories Pvt. Ltd, ELITechGroup, and F. Hoffmann-La Roche Ltd.
| Aspect | Particular |
| Historical Market Estimations | 2020-2022 |
| Base Year for Market Estimation | 2022 |
| Forecast Timeline for Market Projection | 2023-2032 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Product |
|
| Segmentation by Technique |
|
| Segmentation by Application |
|
| Segmentation by End-Use |
|
| Key Companies Profiled |
|
Q1. What is the size of the global antimicrobial susceptibility testing market?
A. The size of the global antimicrobial susceptibility testing market was over $3.7 billion in 2022 and is projected to reach $6.3 billion by 2032.
Q2. Which are the major companies in antimicrobial susceptibility testing market?
A. Bio-Rad Laboratories Inc., Merck & Co., Inc., Thermo Fisher Scientific Inc, Danaher Corporation, BD, bioMérieux SA, Creative Diagnostics, Hi-Media Laboratories Pvt. Ltd, ELITechGroup, and F. Hoffmann-La Roche Ltd. are some of the key players in the global antimicrobial susceptibility testing market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The North America region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Product launch and investment are the two key strategies opted by the operating companies in this market.
Q5. Which companies are investing more on R&D practices?
A. Bio-Rad Laboratories Inc., Merck & Co., Inc., Thermo Fisher Scientific Inc, Danaher Corporation, BD, bioMérieux SA, Creative Diagnostics, Hi-Media Laboratories Pvt. Ltd, ELITechGroup, and F. Hoffmann-La Roche Ltd. are the companies investing more on R&D activities for developing new products and technologies.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Antimicrobial Susceptibility Testing Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Antimicrobial Susceptibility Testing Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Antimicrobial Susceptibility Testing Market, By Infections
5.1. Overview
5.2 Antibacterial Testing
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Antifungal Testing
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Antiparasitic Testing
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Others Susceptibility Testing
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Research Dive Exclusive Insights
5.6.1 Market attractiveness
5.6.2 Competition heatmap
-
6. Antimicrobial Susceptibility Testing Market, By Sector
6.1. Overview
6.2 Automated Laboratory Instruments
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Manual Antimicrobial Susceptibility Testing Products
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Susceptibility Testing Disks
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 MIC strips
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Susceptibility Plates
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Culture and Growth Media
6.7.1 Definition, key trends, growth factors, and opportunities
6.7.2 Market size analysis, by region, 2020-2027
6.7.3 Market share analysis, by country, 2020-2027
6.8 Consumables
6.8.1 Definition, key trends, growth factors, and opportunities
6.8.2 Market size analysis, by region, 2020-2027
6.8.3 Market share analysis, by country, 2020-2027
6.9 Research Dive Exclusive Insights
6.9.1 Market attractiveness
6.9.2 Competition heatmap
-
7. Antimicrobial Susceptibility Testing Market, By Modality
7.1. Overview
7.2 Dilution
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Disk Diffusion
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 ETEST
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Automated Antimicrobial Susceptibility Testing
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Genotypic Methods
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Research Dive Exclusive Insights
7.7.1 Market attractiveness
7.7.2 Competition heatmap
-
8. Antimicrobial Susceptibility Testing Market, By Resorbability
8.1. Overview
8.2 Clinical Diagnostics
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Drug Discovery and Development
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Epidemiology
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Other Applications
8.5.1 Definition, key trends, growth factors, and opportunities
8.5.2 Market size analysis, by region, 2020-2027
8.5.3 Market share analysis, by country, 2020-2027
8.6 Research Dive Exclusive Insights
8.6.1 Market attractiveness
8.6.2 Competition heatmap
-
9. Antimicrobial Susceptibility Testing Market,
9.1. Overview
9.2 Diagnostic Centers and Hospitals
9.2.1 Definition, key trends, growth factors, and opportunities
9.2.2 Market size analysis, by region, 2020-2027
9.2.3 Market share analysis, by country, 2020-2027
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Definition, key trends, growth factors, and opportunities
9.3.2 Market size analysis, by region, 2020-2027
9.3.3 Market share analysis, by country, 2020-2027
9.4 Contract Research Organizations (CROs)
9.4.1 Definition, key trends, growth factors, and opportunities
9.4.2 Market size analysis, by region, 2020-2027
9.4.3 Market share analysis, by country, 2020-2027
9.5 Research and Academic Institutes
9.5.1 Definition, key trends, growth factors, and opportunities
9.5.2 Market size analysis, by region, 2020-2027
9.5.3 Market share analysis, by country, 2020-2027
9.6 Research Dive Exclusive Insights
9.6.1 Market attractiveness
9.6.2 Competition heatmap
10. Antimicrobial Susceptibility Testing Market, By Region
10.1 North America
10.1.1 U.S
10.1.1.1 Market size analysis, By Infections, 2020-2027
10.1.1.2 Market size analysis, By Sector, 2020-2027
10.1.1.3 Market size analysis, By Modality, 2020-2027
10.1.1.4 Market size analysis, By Resorbability, 2020-2027
10.1.1.5 Market size analysis, , 2020-2027
10.1.2 Canada
10.1.2.1 Market size analysis, By Infections, 2020-2027
10.1.2.2 Market size analysis, By Sector, 2020-2027
10.1.2.3 Market size analysis, By Modality, 2020-2027
10.1.2.4 Market size analysis, By Resorbability, 2020-2027
10.1.2.5 Market size analysis, , 2020-2027
10.1.3 Mexico
10.1.3.1 Market size analysis, By Infections, 2020-2027
10.1.3.2 Market size analysis, By Sector, 2020-2027
10.1.3.3 Market size analysis, By Modality, 2020-2027
10.1.3.4 Market size analysis, By Resorbability, 2020-2027
10.1.3.5 Market size analysis, , 2020-2027
10.1.4 Research Dive Exclusive Insights
10.1.4.1 Market attractiveness
10.1.4.2 Competition heatmap
10.2 Europe
10.2.1 Germany
10.2.1.1 Market size analysis, By Infections, 2020-2027
10.2.1.2 Market size analysis, By Sector, 2020-2027
10.2.1.3 Market size analysis, By Modality, 2020-2027
10.2.1.4 Market size analysis, By Resorbability, 2020-2027
10.2.1.5 Market size analysis, , 2020-2027
10.2.2 UK
10.2.2.1 Market size analysis, By Infections, 2020-2027
10.2.2.2 Market size analysis, By Sector, 2020-2027
10.2.2.3 Market size analysis, By Modality, 2020-2027
10.2.2.4 Market size analysis, By Resorbability, 2020-2027
10.2.2.5 Market size analysis, , 2020-2027
10.2.3 France
10.2.3.1 Market size analysis, By Infections, 2020-2027
10.2.3.2 Market size analysis, By Sector, 2020-2027
10.2.3.3 Market size analysis, By Modality, 2020-2027
10.2.3.4 Market size analysis, By Resorbability, 2020-2027
10.2.3.5 Market size analysis, , 2020-2027
10.2.4 Spain
10.2.4.1 Market size analysis, By Infections, 2020-2027
10.2.4.2 Market size analysis, By Sector, 2020-2027
10.2.4.3 Market size analysis, By Modality, 2020-2027
10.2.4.4 Market size analysis, By Resorbability, 2020-2027
10.2.4.5 Market size analysis, , 2020-2027
10.2.5 Italy
10.2.5.1 Market size analysis, By Infections, 2020-2027
10.2.5.2 Market size analysis, By Sector, 2020-2027
10.2.5.3 Market size analysis, By Modality, 2020-2027
10.2.5.4 Market size analysis, By Resorbability, 2020-2027
10.2.5.5 Market size analysis, , 2020-2027
10.2.6 Rest of Europe
10.2.6.1 Market size analysis, By Infections, 2020-2027
10.2.6.2 Market size analysis, By Sector, 2020-2027
10.2.6.3 Market size analysis, By Modality, 2020-2027
10.2.6.4 Market size analysis, By Resorbability, 2020-2027
10.2.6.5 Market size analysis, , 2020-2027
10.2.7 Research Dive Exclusive Insights
10.2.7.1 Market attractiveness
10.2.7.2 Competition heatmap
10.3 Asia-Pacific
10.3.1 China
10.3.1.1 Market size analysis, By Infections, 2020-2027
10.3.1.2 Market size analysis, By Sector, 2020-2027
10.3.1.3 Market size analysis, By Modality, 2020-2027
10.3.1.4 Market size analysis, By Resorbability, 2020-2027
10.3.1.5 Market size analysis, , 2020-2027
10.3.2 Japan
10.3.2.1 Market size analysis, By Infections, 2020-2027
10.3.2.2 Market size analysis, By Sector, 2020-2027
10.3.2.3 Market size analysis, By Modality, 2020-2027
10.3.2.4 Market size analysis, By Resorbability, 2020-2027
10.3.2.5 Market size analysis, , 2020-2027
10.3.3 India
10.3.3.1 Market size analysis, By Infections, 2020-2027
10.3.3.2 Market size analysis, By Sector, 2020-2027
10.3.3.3 Market size analysis, By Modality, 2020-2027
10.3.3.4 Market size analysis, By Resorbability, 2020-2027
10.3.3.5 Market size analysis, , 2020-2027
10.3.4 Australia
10.3.4.1 Market size analysis, By Infections, 2020-2027
10.3.4.2 Market size analysis, By Sector, 2020-2027
10.3.4.3 Market size analysis, By Modality, 2020-2027
10.3.4.4 Market size analysis, By Resorbability, 2020-2027
10.3.4.5 Market size analysis, , 2020-2027
10.3.5 South Korea
10.3.5.1 Market size analysis, By Infections, 2020-2027
10.3.5.2 Market size analysis, By Sector, 2020-2027
10.3.5.3 Market size analysis, By Modality, 2020-2027
10.3.5.4 Market size analysis, By Resorbability, 2020-2027
10.3.5.5 Market size analysis, , 2020-2027
10.3.6 Rest of Asia-Pacific
10.3.6.1 Market size analysis, By Infections, 2020-2027
10.3.6.2 Market size analysis, By Sector, 2020-2027
10.3.6.3 Market size analysis, By Modality, 2020-2027
10.3.6.4 Market size analysis, By Resorbability, 2020-2027
10.3.6.5 Market size analysis, , 2020-2027
10.3.7 Research Dive Exclusive Insights
10.3.7.1 Market attractiveness
10.3.7.2 Competition heatmap
10.4 LAMEA
10.4.1 Brazil
10.4.1.1 Market size analysis, By Infections, 2020-2027
10.4.1.2 Market size analysis, By Sector, 2020-2027
10.4.1.3 Market size analysis, By Modality, 2020-2027
10.4.1.4 Market size analysis, By Resorbability, 2020-2027
10.4.1.5 Market size analysis, , 2020-2027
10.4.2 Saudi Arabia
10.4.2.1 Market size analysis, By Infections, 2020-2027
10.4.2.2 Market size analysis, By Sector, 2020-2027
10.4.2.3 Market size analysis, By Modality, 2020-2027
10.4.2.4 Market size analysis, By Resorbability, 2020-2027
10.4.2.5 Market size analysis, , 2020-2027
10.4.3 UAE
10.4.3.1 Market size analysis, By Infections, 2020-2027
10.4.3.2 Market size analysis, By Sector, 2020-2027
10.4.3.3 Market size analysis, By Modality, 2020-2027
10.4.3.4 Market size analysis, By Resorbability, 2020-2027
10.4.3.5 Market size analysis, , 2020-2027
10.4.4 South Africa
10.4.4.1 Market size analysis, By Infections, 2020-2027
10.4.4.2 Market size analysis, By Sector, 2020-2027
10.4.4.3 Market size analysis, By Modality, 2020-2027
10.4.4.4 Market size analysis, By Resorbability, 2020-2027
10.4.4.5 Market size analysis, , 2020-2027
10.4.5 Rest of LAMEA
10.4.5.1 Market size analysis, By Infections, 2020-2027
10.4.5.2 Market size analysis, By Sector, 2020-2027
10.4.5.3 Market size analysis, By Modality, 2020-2027
10.4.5.4 Market size analysis, By Resorbability, 2020-2027
10.4.5.5 Market size analysis, , 2020-2027
10.4.6 Research Dive Exclusive Insights
10.4.6.1 Market attractiveness
10.4.6.2 Competition heatmap
11. Competitive Landscape
11.1 Top winning strategies, 2020-2027
11.1.1 By strategy
11.1.2 By year
11.2 Strategic overview
11.3 Market share analysis, 2020-2027
12. Company Profiles
12.1 bioMérieux
12.1.1 Overview
12.1.2 Business segments
12.1.3 Product portfolio
12.1.4 Financial performance
12.1.5 Recent developments
12.1.6 SWOT analysis
12.2 BD
12.2.1 Overview
12.2.2 Business segments
12.2.3 Product portfolio
12.2.4 Financial performance
12.2.5 Recent developments
12.2.6 SWOT analysis
12.3 Danaher
12.3.1 Overview
12.3.2 Business segments
12.3.3 Product portfolio
12.3.4 Financial performance
12.3.5 Recent developments
12.3.6 SWOT analysis
12.4 Thermo Fisher
12.4.1 Overview
12.4.2 Business segments
12.4.3 Product portfolio
12.4.4 Financial performance
12.4.5 Recent developments
12.4.6 SWOT analysis
12.5 Bio-Rad
12.5.1 Overview
12.5.2 Business segments
12.5.3 Product portfolio
12.5.4 Financial performance
12.5.5 Recent developments
12.5.6 SWOT analysis
12.6 Hi-Media
12.6.1 Overview
12.6.2 Business segments
12.6.3 Product portfolio
12.6.4 Financial performance
12.6.5 Recent developments
12.6.6 SWOT analysis
12.7 MERLIN
12.7.1 Overview
12.7.2 Business segments
12.7.3 Product portfolio
12.7.4 Financial performance
12.7.5 Recent developments
12.7.6 SWOT analysis
12.8 Liofilchem
12.8.1 Overview
12.8.2 Business segments
12.8.3 Product portfolio
12.8.4 Financial performance
12.8.5 Recent developments
12.8.6 SWOT analysis
12.9 Accelerate
12.9.1 Overview
12.9.2 Business segments
12.9.3 Product portfolio
12.9.4 Financial performance
12.9.5 Recent developments
12.9.6 SWOT analysis
12.10 Alifax
12.10.1 Overview
12.10.2 Business segments
12.10.3 Product portfolio
12.10.4 Financial performance
12.10.5 Recent developments
12.10.6 SWOT analysis
12.11 Creative Diagnostics
12.11.1 Overview
12.11.2 Business segments
12.11.3 Product portfolio
12.11.4 Financial performance
12.11.5 Recent developments
12.11.6 SWOT analysis
12.12 Merck Group(us), Synbiosis
12.12.1 Overview
12.12.2 Business segments
12.12.3 Product portfolio
12.12.4 Financial performance
12.12.5 Recent developments
12.12.6 SWOT analysis
12.13 Bioanalyse
12.13.1 Overview
12.13.2 Business segments
12.13.3 Product portfolio
12.13.4 Financial performance
12.13.5 Recent developments
12.13.6 SWOT analysis
12.14 Zhuhai DL Biotech
12.14.1 Overview
12.14.2 Business segments
12.14.3 Product portfolio
12.14.4 Financial performance
12.14.5 Recent developments
12.14.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
